How to make more cancers vulnerable to immunotherapies
Cancer immunotherapies called checkpoint inhibitors can bring dramatic, life-saving results – but only for a limited fraction of patients. Aiming to help more patients benefit, researchers in...
Tag: philanthropy
Understanding the accomplice cells that help drive pancreatic cancer
Mara Sherman’s award-winning research is uncovering the role of non-cancer cells that support tumor growth in pancreatic ductal adenocarcinoma. The pancreatic cancer survival rate, averaging...
An elaborate clinical trial aims a multitude of targeted therapies at one formidable cancer
A $10 million gift from The Harry T. Mangurian Jr. Foundation will help The Leukemia & Lymphoma Society expand the Beat AML Master Trial underway at the OHSU Knight Cancer Institute and other...
Check out the Knight Cancer pilot project award winners
Preventing skin cancer with a DNA-repair enzyme. Understanding how microRNAs modify cancer immunity. Using zebrafish embryos to rapidly assess toxicity of anticancer drug combinations. These are...
With foundation help, an Oregon doctor roots out low-value medical practices
Physicians have started to face up to an uncomfortable truth: their profession has often embraced new treatments that don't really help patients. "When you look at the balance of benefit and harm,...
First in philanthropy: Phil and Penny Knight
Phil Knight and Brian Druker, M.D., on "Good Morning America" in 2015. Nike co-founder Phil Knight and his wife Penny ranked no. 1 in The Chronicle of Philanthropy list of Americans who donated...